SWE ORPHAN BIOVITRU
SWE ORPHAN BIOVITRU operates in Diversified Metals & Mining.
SWE ORPHAN BIOVITRU (B6E) - Net Assets
Latest net assets as of September 2024: €37.11 Billion EUR
Based on the latest financial reports, SWE ORPHAN BIOVITRU (B6E) has net assets worth €37.11 Billion EUR as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€72.19 Billion) and total liabilities (€35.09 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €37.11 Billion |
| % of Total Assets | 51.4% |
| Annual Growth Rate | 30.16% |
| 5-Year Change | 100.04% |
| 10-Year Change | N/A |
| Growth Volatility | 23.6 |
SWE ORPHAN BIOVITRU - Net Assets Trend (2016–2023)
This chart illustrates how SWE ORPHAN BIOVITRU's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SWE ORPHAN BIOVITRU (2016–2023)
The table below shows the annual net assets of SWE ORPHAN BIOVITRU from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €33.87 Billion | +27.68% |
| 2022-12-31 | €26.52 Billion | +14.32% |
| 2021-12-31 | €23.20 Billion | +14.83% |
| 2020-12-31 | €20.21 Billion | +19.35% |
| 2019-12-31 | €16.93 Billion | +87.28% |
| 2018-12-31 | €9.04 Billion | +34.92% |
| 2017-12-31 | €6.70 Billion | +25.14% |
| 2016-12-31 | €5.35 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to SWE ORPHAN BIOVITRU's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4543.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €18.05 Billion | 53.31% |
| Other Components | €15.81 Billion | 46.69% |
| Total Equity | €33.87 Billion | 100.00% |
SWE ORPHAN BIOVITRU Competitors by Market Cap
The table below lists competitors of SWE ORPHAN BIOVITRU ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
WDCX
BATS:WDCX
|
$358.74K |
|
AMPD Ventures Inc
PINK:AMPDF
|
$358.85K |
|
CHINA YUCHAI INTL (CYD.SG)
STU:CYD
|
$359.06K |
|
Entreprendre
PA:ALENR
|
$359.08K |
|
FOBANK
CO:FOBANK
|
$358.19K |
|
RheinLand Holding AG
DU:RLV
|
$357.90K |
|
Groove Botanicals Inc
PINK:GRVE
|
$357.83K |
|
Direct Digital Holdings Inc
NASDAQ:DRCT
|
$357.19K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SWE ORPHAN BIOVITRU's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 26,525,000,000 to 33,867,000,000, a change of 7,342,000,000 (27.7%).
- Net income of 2,409,000,000 contributed positively to equity growth.
- New share issuances of 6,129,000,000 increased equity.
- Other factors decreased equity by 1,196,000,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €2.41 Billion | +7.11% |
| Share Issuances | €6.13 Billion | +18.1% |
| Other Changes | €-1.20 Billion | -3.53% |
| Total Change | €- | 27.68% |
Book Value vs Market Value Analysis
This analysis compares SWE ORPHAN BIOVITRU's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.36x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.46x to 0.36x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €24.89 | €36.24 | x |
| 2018-12-31 | €33.49 | €36.24 | x |
| 2019-12-31 | €57.53 | €36.24 | x |
| 2020-12-31 | €65.45 | €36.24 | x |
| 2021-12-31 | €75.09 | €36.24 | x |
| 2022-12-31 | €85.59 | €36.24 | x |
| 2023-12-31 | €99.68 | €36.24 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SWE ORPHAN BIOVITRU utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.11%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.89%
- • Asset Turnover: 0.30x
- • Equity Multiplier: 2.19x
- Recent ROE (7.11%) is below the historical average (15.40%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 15.11% | 15.55% | 0.52x | 1.86x | €273.64 Million |
| 2017 | 17.14% | 17.64% | 0.60x | 1.63x | €478.56 Million |
| 2018 | 26.75% | 26.46% | 0.53x | 1.90x | €1.51 Billion |
| 2019 | 19.52% | 23.19% | 0.31x | 2.70x | €1.61 Billion |
| 2020 | 16.06% | 21.26% | 0.32x | 2.39x | €1.22 Billion |
| 2021 | 11.55% | 17.25% | 0.32x | 2.10x | €358.70 Million |
| 2022 | 9.95% | 14.04% | 0.36x | 1.98x | €-14.50 Million |
| 2023 | 7.11% | 10.89% | 0.30x | 2.19x | €-977.70 Million |
Industry Comparison
This section compares SWE ORPHAN BIOVITRU's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SWE ORPHAN BIOVITRU (B6E) | €37.11 Billion | 15.11% | 0.95x | $358.38K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |